Imcheck Therapeutics
ID: 6710798Immuno-modulatory antibodies
4
Funding Rounds
$277.9m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ha** He**** Ch********* | - | - | |
| Pa** Fr**** | - | - | |
| Lo** Ma********* | - | - | |
| Cl**** Kn*** | - | - | |
| Pi**** d�********* | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Imcheck Therapeutics has raised a total of $277.85m in funding over 4 rounds.
Key Insights:
- Imcheck Therapeutics Series C round, June 2022: $103m
- ImCheck Therapeutics June 2022 Funding Round: $100m
- ImCheck Therapeutics Series B round, December 2019: $53m
- ImCheck Therapeutics Series A round, May 2017: $21.85m
Industries
Imcheck Therapeutics is active in the following industries: